论文部分内容阅读
目的 评价经导管肝动脉化疗栓塞在晚期肝癌治疗中的价值。方法 文中对１２ 例肝癌经股动脉行肝动脉化疗栓塞。结果 半年生存率３３％ ，达到了改善病人生活质量、延长生存时间的目的。结论 对于晚期肝癌病人，只要一般情况尚可，应积极治疗，但治疗方案要个体化，这样才能在取得较好疗效的同时又不致产生过多的负效应。
Objective To evaluate the value of transcatheter arterial chemoembolization in the treatment of advanced liver cancer. Methods Twelve cases of hepatocellular carcinoma were treated with hepatic arterial chemoembolization via the femoral artery. Results The half-year survival rate was 33%, which achieved the goal of improving the patient’s quality of life and prolonging the survival time. Conclusion For patients with advanced liver cancer, as long as the general situation is acceptable, they should be actively treated, but the treatment plan should be individualized, so as to achieve better results without causing excessive negative effects.